AI Insight
Researchers have identified a previously unknown mechanism by which high-cholesterol diets interfere with the body's natural ability to regulate cholesterol levels. In mouse studies, blocking this pathway resulted in significant reductions in LDL (low-density lipoprotein) cholesterol, the harmful form associated with cardiovascular disease. An experimental drug targeting this mechanism has already completed Phase 1 human safety trials, suggesting a potentially faster route to clinical application.
Why it matters
This discovery could lead to new therapeutic options for managing high cholesterol, particularly for patients who do not respond adequately to existing treatments like statins. The fact that a candidate drug has already demonstrated safety in humans may accelerate the timeline for developing effective cholesterol-lowering medications based on this novel mechanism.
Understand the Science
Scientists have uncovered a hidden mechanism that allows high-cholesterol diets to undermine the body’s natural cholesterol defenses, and blocking it dramatically lowered harmful LDL cholesterol in mice. Even more promising, an experimental drug targeting this pathway has already passed an early human safety trial, potentially speeding the development of a new treatment for high cholesterol.
Source: Scientists discover a hidden driver of high cholesterol and a way to stop it